...
首页> 外文期刊>The journal of pain: official journal of the American Pain Society >Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.
【24h】

Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.

机译:先前的挑战可以增强疼痛强度和持续时间:表明小胶质启动作用的初步证据。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Activation of spinal microglia and consequent release of proinflammatory mediators facilitate pain. Under certain conditions, responses of activated microglia can become enhanced. Enhanced microglial production of proinflammatory products may result from priming (sensitization), similar to macrophage priming. We hypothesized that if spinal microglia were primed by an initial inflammatory challenge, subsequent challenges may create enhanced pain. Here, we used a two-hit populations of spinal microglia, presented 2 weeks apart. Mechanical allodynia and/or activation of spinal glia were assessed. Initially, laparotomy preceded systemic lipopolysaccharide (LPS). Prior laparotomy caused prolonged microglial (not astrocyte) activation plus enhanced LPS-induced allodynia. In this "two-hit" paradigm, minocycline, a microglial activation inhibitor, significantly reduced later exaggerated pain induced by prior surgery when minocycline was administered intrathecally for 5 days starting either at the time of surgery or 5 days before LPS administration. To test generality of the priming effect, subcutaneous formalin preceded intrathecal HIV-1 gp120, which activates spinal microglia and causes robust allodynia. Prior formalin enhanced intrathecal gp120-induced allodynia, suggesting that microglial priming is not limited to laparotomy and again supporting a spinal site of action. Therefore, spinal microglial priming may increase vulnerability to pain enhancement. PERSPECTIVE: Spinal microglia may become "primed" (sensitized) following their activation by disparate forms of peripheral trauma/inflammation. As a result, such primed microglia may overrespond to subsequent challenges, thereby enhancing pain intensity and duration.
机译:脊髓小胶质细胞的活化和随后促炎介质的释放促进疼痛。在某些条件下,活化的小胶质细胞的反应会增强。类似于巨噬细胞启动,启动(敏化)可导致促炎产物的小胶质细胞产生增强。我们假设,如果脊髓小胶质细胞由最初的炎症刺激引发,随后的挑战可能会加剧疼痛。在这里,我们使用了两次打击的脊髓小胶质细胞,两次间隔。评估机械性异常性疼痛和/或脊髓神经胶质细胞的激活。最初,剖腹手术先于全身性脂多糖(LPS)。先前的剖腹手术会导致小胶质细胞(而非星形胶质细胞)活化时间延长,以及LPS诱导的异常性疼痛增强。在这种“两次打击”的范例中,米诺环素是一种小胶质细胞激活抑制剂,当从手术时或LPS给药前5天开始鞘内给予米诺环素5天时,可显着减轻后来因先前手术引起的过度疼痛。为了测试引发作用的普遍性,皮下注射福尔马林在鞘内注射HIV-1 gp120,然后激活脊髓小胶质细胞并引起强烈的异常性疼痛。先前的福尔马林增强了鞘内注射gp120引起的异常性疼痛,这表明小胶质细胞灌注不仅限于剖腹手术,而且再次支持脊柱活动部位。因此,脊柱小神经胶质引发可能增加疼痛增强的脆弱性。透视:脊髓小胶质细胞在被不同形式的周围创伤/炎症激活后可能会被“引发”(致敏)。结果,这种引发的小胶质细胞可能对随后的挑战反应过度,从而增加了疼痛强度和持续时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号